A Phase II Study of KUC-7483 in Patients With Overactive Bladder

A Randomized, Double Blind, Placebo Controlled, Phase II Study of KUC-7483 in Patients With Overactive Bladder

To investigate the efficacy and safety of KUC-7483 in overactive bladder patients.

Inclusion Criteria:

• Patients with a symptom of overactive bladder for more than 6 months.

• Patients who meet the following condition during the 3-day bladder diary period.

  • the mean number of micturitions per 24 hours is ≥8 times
  • the mean number of urgency episodes per 24 hours is ≥1 time

Exclusion Criteria:

• Patients who are diagnosed as stress urinary incontinence are predominant.
• Patients with urinary calculus, interstitial cystitis, or clinically significant urinary tract infection.